|Bid||56.00 x 1800|
|Ask||56.19 x 800|
|Day's Range||55.94 - 56.82|
|52 Week Range||51.72 - 82.15|
|Beta (3Y Monthly)||1.05|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||2.00 (3.56%)|
|1y Target Est||N/A|
The new funding will support approximately 130 Free & Charitable Clinics in their efforts to help patients manage chronic disease, provide more wraparound services to address the social determinants of health and support treatment and prevention of substance abuse, including opioid and tobacco. The new funds bring the company and the CVS Health Foundation's total contribution to NAFC to nearly $8 million since 2015.
WOONSOCKET, R.I., July 17, 2019 /PRNewswire/ -- CVS Health (CVS) today announced the initiation of a clinical trial designed to evaluate the safety and efficacy of the HemoCare™ Hemodialysis System for administration of home hemodialysis. The innovative device includes safety features and is designed to make home hemodialysis simple for patients. Home hemodialysis helps facilitate longer, more frequent dialysis treatments as compared to in-center treatments, and published clinical research has found that longer, more frequent hemodialysis treatments result in better health outcomes in appropriate patient populations.1,2,3 The clinical trial of up to 70 patients will be conducted at up to ten sites in the United States.
WOONSOCKET, R.I. , July 10, 2019 /PRNewswire/ -- CVS Health Corporation (NYSE: CVS) today announced that its board of directors has approved a quarterly dividend of $0.50 ( 50 cents ) per share on the ...
WOONSOCKET, R.I., July 10, 2019 /PRNewswire/ -- CVS Pharmacy, the retail division of CVS Health (CVS), today announced the expansion of its safe medication disposal program in Ohio, adding disposal units in 53 CVS Pharmacy stores in communities across the state, including Cincinnati, Cleveland, Columbus, Dayton, Toledo and Youngstown. The expanded program is designed to help address the diversion and misuse of unwanted or unneeded prescription drugs in Ohio.
WOONSOCKET, R.I., July 10, 2019 /PRNewswire/ -- CVS Health (CVS) today announced that MinuteClinic, the company's retail medical clinic, has rolled out its virtual visit offering in eight additional states. People with minor illnesses and injuries, skin conditions and other wellness needs can now seek care through MinuteClinic Video Visits, a telehealth offering, in the states of Arkansas, Connecticut, Hawaii, Indiana, Minnesota, Missouri, Oklahoma and Texas. MinuteClinic Video Visits provide patients with access to care 24 hours a day, seven days a week from their mobile device or computer.
WOONSOCKET, R.I., July 2, 2019 /PRNewswire/ -- As part of its commitment to helping build healthier communities, CVS Pharmacy, the retail division of CVS Health (CVS), today applauded Governor David Ige and the state legislature for enacting new legislation (HB-1272) that will enable the installation of safe medication disposal units this month in many Longs Drugs locations across Hawaii. CVS Health and CVS Pharmacy operate Longs Drugs in Hawaii.
WOONSOCKET, R.I., June 24, 2019 /PRNewswire/ -- CVS Pharmacy, the retail division of CVS Health (CVS), announced today that it has completed the rollout of time delay safes in all of its 318 CVS Pharmacy locations in Michigan, including pharmacies located in Target stores. The safes are anticipated to help prevent pharmacy robberies and the diversion of controlled substance narcotic medications by keeping them out of the hands of unauthorized individuals.
WOONSOCKET, R.I., June 17, 2019 /PRNewswire/ -- Given the significant increase in the number of teens using e-cigarettes, CVS Health today announced that it and its charitable foundations will award a total of more than $10 million in 2019 to support youth smoking and e-cigarette prevention strategies and education delivered in classrooms, by clinicians and in communities across the United States. The new commitment, funded through the company and the CVS Health and Aetna Foundations, is part of Be The First, CVS Health's five-year $50 million initiative to help deliver the nation's first tobacco-free generation. According to the 2018 National Youth Tobacco Survey, there are 3.6 million middle and high school students who are current e-cigarette users, a dramatic increase from the more than 1.5 million students the previous year.
WOONSOCKET, R.I., June 11, 2019 /PRNewswire/ -- CVS Health (CVS) today announced the availability of Vendor Benefit Management, a new service developed to help CVS Caremark pharmacy benefit management (PBM) clients more easily contract, implement and manage their choice of available and emerging third-party health and wellness benefit solutions – both digital and non-digital. This new service offers clients a seamless way to access negotiated pricing, standardized member eligibility verification in real-time, simplified billing and payment processing, and standardized results measurement and reporting across multiple vendors. Big Health, a digital therapeutics company, is the first participating vendor, and Sleepio, its automated, personalized digital sleep improvement program, will be available to CVS Caremark clients via Vendor Benefit Management.
SAN DIEGO, June 04, 2019 -- The Shareholders Foundation, Inc. announces that a lawsuit was filed for investors who formerly held Aetna Inc (NYSE: AET) shares. Investors, who.
Significant Expansion of HealthHUBs ® will Help Drive Differentiated, Consumer-Centric Health Experience; 1,500 Expected to Open by End of 2021 Strong Execution on Aetna Integration Projected to Drive ...
TORONTO , May 30, 2019 /CNW/ - Abacus Health Products, Inc. (ABCS.CN) ("Abacus" or the "Company") reported its financial results today for the first quarter ended March 31, 2019 . CBD CLINIC continued to perform well with revenue increasing 148% YoY, from $1,433,243 to $3,553,751 , and an increase of 23% over the fourth quarter of 2018, from $2,886,412 . Purchase orders received to date represent over 2,000 retail pharmacy and supermarket locations across 11 states.
WOONSOCKET, R.I., May 21, 2019 /PRNewswire/ -- CVS Health Corporation (CVS) will hold its Investor Day in New York City on Tuesday, June 4, 2019, beginning at 8:00 a.m. (ET). Senior members of the CVS Health leadership team will provide an in-depth review of the company's strategies to drive long-term growth and enhance shareholder value. An audio and video webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website for all interested parties, and will be archived and available for a one-year period.
WOONSOCKET, R.I., May 15, 2019 /PRNewswire/ -- CVS Pharmacy, the retail division of CVS Health (CVS), today announced the launch of "Tested to Be Trusted", a program requiring third-party testing of all vitamins and supplements sold in-store and online to confirm the accuracy of the dietary ingredients listed on the supplement facts panel and to confirm products are free from certain additives and ingredients. 1,400 vitamins and supplements from 152 brands across 11 categories, including diet and nutrition, pain and digestive, have completed testing. The expanded assortment and new vitamin and supplement testing standards are the latest evolution in CVS Pharmacy's commitment to being a trusted partner in health and holistic wellness, and are the focus of a new campaign dedicated to the importance of self-care.
VANCOUVER and DENVER, CO , May 14, 2019 /CNW/ - Cannabis One Holdings Inc. (CBIS.CN) ("Cannabis One", "CBIS", or the "Company"), an emerging, premier "House of Brands" in North America , is pleased to announce that it is expanding its multi-state footprint for both CBD and THC-infused products with the leasing of two (2) manufacturing and processing facilities in the State of Oregon , totaling over 21,000 ft2. Located near Portland, Oregon , the Company is transitioning the existing facilities into state-of-the-art manufacturing and distribution centers.
WOONSOCKET, RI and TORONTO, May 10, 2019 /CNW/ - Abacus Health Products, Inc. (ABCS.CN) ("Abacus" or the "Company") today announced further growth in the distribution and availability of their line of CBDMEDIC™ products. "These purchase orders, which range from six to twelve unique SKUs across our pain relief and therapeutic skincare lines, demonstrate the continued strong interest by retail chains to bring CBDMEDIC™ products onto their shelves," said Perry Antelman , CEO of Abacus. Further, a 2018 research report by Allied Market Research estimated the global topical pain relief market to be approximately US$7.4 billion in 2017.
WOONSOCKET, R.I., May 9, 2019 /PRNewswire/ -- CVS Pharmacy, the retail division of CVS Health (CVS), announced today that it has completed the rollout of time delay safes in all of its 140 CVS Pharmacy locations in Minnesota, including in Target stores. The safes are anticipated to help prevent pharmacy robberies and the diversion of controlled substance narcotic medications by keeping them out of the hands of unauthorized individuals.
32 Project Health events will help address access, affordability and quality care Company also presented $75,000 grant to Sacramento Native American Health Center to expand opioid treatment options locally ...
HOUSTON, TX / ACCESSWIRE / May 1, 2019 / Revenue generated from sales of CBD skin care products could grow to $645 million in 2019, according to Future Market Insights' report, CBD Skin Care Market: Global ...
2019 EPS Guidance Raised And Narrowed To Reflect Strong Performance Year-to-Date WOONSOCKET, R.I. , May 1, 2019 /PRNewswire/ -- First Quarter Year-over-Year Highlights: Revenues increased 34.8% to $61.6 ...
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CVS Health Corporation (“CVS” or “the Company”) (NYSE: CVS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period.
ClaimsFiler, a FREE shareholder information service, reminds investors that they have only until April 26, 2019 to file lead plaintiff applications in a securities class action lawsuit against CVS Health Corporation .
NEW YORK, NY / ACCESSWIRE / April 25, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have ...
LOS ANGELES, CA / ACCESSWIRE / April 25, 2019 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against CVS Health Corporation ("CVS" ...